Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid
    1.
    发明申请
    Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid 审中-公开
    通常使用过氧单硫酸盐的人体药物治疗

    公开(公告)号:US20110229583A1

    公开(公告)日:2011-09-22

    申请号:US12726326

    申请日:2010-03-17

    CPC classification number: A61K33/40 A61K31/185

    Abstract: A medicinal drug is administered to a person for treating a medical condition of the person or/and for preventing the person from contracting the medical condition. The medical condition can be a bacterial infection, a eukaryotic infection, a prion-caused infection, a non-pathogenic inflammation, and, insofar as not covered by any of these four types of the medical condition, a fungal infection, a spore-caused infection, and a parasitic infection. A medicinal drug is similarly administered non-topically to a person for treating a virus-caused medical condition of the person or/and for preventing the person from contracting the virus-caused medical condition. The medicinal drug is typically formed at least partially with salt of peroxymonosulfuric acid, preferably potassium hydrogen peroxymonosulfate.

    Abstract translation: 药物被用于治疗患者的医疗状况或/或用于防止该人感染医疗状况的人。 医疗状况可以是细菌感染,真核感染,朊病毒引起的感染,非致病性炎症,并且在这四种类型的医学病症中没有被覆盖,真菌感染,孢子引起的 感染和寄生虫感染。 类似地,药物非局部地用于治疗患者的病毒引起的医疗状况或/或用于防止该人感染病毒引起的疾病的人。 药物通常至少部分地与过氧单硫酸盐,优选过硫酸氢钾一起形成。

    PRODUCT TYPICALLY BASED ON SALT OF PEROXYMONOSULFURIC ACID AND SUITABLE FOR MEDICINAL USAGE, AND ASSOCIATED PRODUCT FABRICATION
    2.
    发明申请
    PRODUCT TYPICALLY BASED ON SALT OF PEROXYMONOSULFURIC ACID AND SUITABLE FOR MEDICINAL USAGE, AND ASSOCIATED PRODUCT FABRICATION 审中-公开
    基于过氧化脂肪酸盐和适用于药物使用的产品,以及相关产品制造

    公开(公告)号:US20120074014A1

    公开(公告)日:2012-03-29

    申请号:US13047742

    申请日:2011-03-14

    CPC classification number: C01B15/08 A61K31/327 Y10T29/49826

    Abstract: Products based on salt of peroxymonosulfuric acid are suitable for treating or/and preventing diseases and other debilitating medical conditions caused by bacterial, eukaryotic, prion, and viral pathogens and by non-pathogenic inflammation. The products may alternatively be based on inorganic halide and an oxidizing agent reactable in water with the inorganic halide to generate hypohalite ions. In addition, the products can be employed in other applications such as commercial and industrial applications.

    Abstract translation: 基于过氧单硫酸盐的产品适用于治疗和/或预防由细菌,真核生物,朊病毒和病毒病原体引起的疾病和其他虚弱的疾病,以及非致病性炎症。 产物可替代地基于无机卤化物和在水中与无机卤化物反应以产生次卤酸盐离子的氧化剂。 此外,该产品可用于其他应用,如商业和工业应用。

Patent Agency Ranking